Advanced search
Publication Cover
Expert Review of Hematology Volume 7, 2014 - Issue 2
Submit an article Journal homepage
233
Views
19
CrossRef citations to date
0
Altmetric
Reviews

The emerging role of carfilzomib combination therapy in the management of multiple myeloma

Philippe MoreauHematology Department, University Hospital Hôtel-Dieu, 44093, Nantes Cedex 01, FranceCorrespondence[email protected]
Pages 265-290 | Published online: 12 Feb 2014

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Katelyn G. Ponder, Shannon M. Matulis, Sadae Hitosugi, Vikas A. Gupta, Cathy Sharp, Francis Burrows, Ajay K. Nooka, Jonathan L. Kaufman, Sagar Lonial & Lawrence H. Boise. (2016) Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myeloma. Cancer Biology & Therapy 17:7, pages 769-777.
Read now
Koichiro Hayashi, Sakamoto Wataru & Toshinobu Yogo. (2014) Iodinated silica/porphyrin hybrid nanoparticles for X-ray computed tomography/fluorescence dual-modal imaging of tumors. Journal of Asian Ceramic Societies 2:4, pages 429-434.
Read now
Tanya R Porras-Yakushi & Sonja Hess. (2014) Recent advances in defining the ubiquitylome. Expert Review of Proteomics 11:4, pages 477-490.
Read now

Articles from other publishers (16)

Salvatore Pacifico, Valeria Ferretti, Valentina Albanese, Anna Fantinati, Eleonora Gallerani, Francesco Nicoli, Riccardo Gavioli, Francesco Zamberlan, Delia Preti & Mauro Marastoni. (2019) Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors. ACS Medicinal Chemistry Letters 10:7, pages 1086-1092.
Crossref
V. Lavanya, Shazia Jamal & Neesar Ahmed. 2019. Protein Modificomics. Protein Modificomics 109 130 .
Muhammad Arba, Andry Nur-Hidayat, Slamet Ibrahim Surantaadmaja & Daryono H. Tjahjono. (2018) Pharmacophore-based virtual screening for identifying β5 subunit inhibitor of 20S proteasome. Computational Biology and Chemistry 77, pages 64-71.
Crossref
Muhammad Arba, Andry Nur-Hidayat, Ruslin, Muhammad Yusuf, Sumarlin, Rukman Hertadi, Setyanto Tri Wahyudi, Slamet Ibrahim Surantaadmaja & Daryono H. Tjahjono. (2018) Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome. Computational Biology and Chemistry 74, pages 230-238.
Crossref
Emily E. Robinson & Regan J. Thomson. (2018) A Strategy for the Convergent and Stereoselective Assembly of Polycyclic Molecules. Journal of the American Chemical Society 140:5, pages 1956-1965.
Crossref
Carlos Roberto Koscky Paier, Sarah Sant'Anna Maranhão, Teiliane Rodrigues Carneiro, Lídia Moreira Lima, Danilo Damasceno Rocha, Renan da Silva Santos, Kaio Moraes de Farias, Manoel Odorico de Moraes-Filho & Claudia Pessoa. (2018) Natural products as new antimitotic compounds for anticancer drug development. Clinics 73, pages e813s.
Crossref
Philipp M. Cromm & Craig M. Crews. (2017) The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target. ACS Central Science 3:8, pages 830-838.
Crossref
J. Ciavarri & S. Langston. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 95 112 .
Jonghoon Park, Eok Park, Cheol-Kyu Jung, Seung-Wan Kang, Byung Gyu Kim, Youngjoo Jung, Tae Hun Kim, Ji-Young Lim, Sung-Eun Lee, Chang-Ki Min & Kwang-Ai Won. (2016) Oral proteasome inhibitor with strong preclinical efficacy in myeloma models. BMC Cancer 16:1.
Crossref
A Keith Stewart. (2015) Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma. Future Oncology 11:15, pages 2121-2136.
Crossref
Beverly A. Teicher & Joseph E. Tomaszewski. (2015) Proteasome inhibitors. Biochemical Pharmacology 96:1, pages 1-9.
Crossref
Paul G Richardson, Philippe Moreau, Jacob P Laubach, Neeraj Gupta, Ai-Min Hui, Kenneth C Anderson, Jesús F San Miguel & Shaji Kumar. (2015) The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma. Future Oncology 11:8, pages 1153-1168.
Crossref
Lu Gao, Minjie Gao, Guang Yang, Yi Tao, Yuanyuan Kong, Ruixue Yang, Xiuqin Meng, Gongwen Ai, Rong Wei, Huiqun Wu, Xiaosong Wu & Jumei Shi. (2015) Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2. BioMed Research International 2015, pages 1-9.
Crossref
Philippe Moreau. (2014) Oral therapy for multiple myeloma: ixazomib arriving soon. Blood 124:7, pages 986-987.
Crossref
E.K. Mai & H. Goldschmidt. (2014) Klinik und Therapie des multiplen MyelomsClincal features and treatment of multiple myeloma. Der Radiologe 54:6, pages 538-544.
Crossref
Jeffrey A. Zonder. 2014. Resistance to Proteasome Inhibitors in Cancer. Resistance to Proteasome Inhibitors in Cancer 99 115 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.